OC
GSK icon

Opal Capital’s GSK GSK Stock Holding History

Opal Capital’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.71M Sell
108,899
-6,423
-6% -$340K 1.02% 32
2026
Q1 		$6.36M Buy
115,322
+14,047
+14% +$761K 1.13% 29
2025
Q4 		$4.97M Buy
+101,275
New +$4.72M 1.24% 28

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Opal Capital's GSK Position: Q2 2026 in Review

Opal Capital reduced its GSK (GSK) stake by 5.6% in Q2 2026, selling an estimated $340K and leaving 108,899 shares worth $5.71M. The position accounts for 1.02% of the portfolio, ranked #32.

Opal Capital first reported a position in GSK in Q4 2025 and has held it in 3 quarters since. The position peaked at $6.36M in Q1 2026. 1,045 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Opal Capital held 108,899 shares of GSK worth $5.71M as of Q2 2026.
  • Opal Capital sold 6,423 GSK shares in Q2 2026, an estimated $340K.
  • GSK made up 1.02% of Opal Capital's portfolio in Q2 2026, its #32 holding.
  • Opal Capital first reported a position in GSK in Q4 2025 and has held it in 3 quarters since.
  • Opal Capital's GSK position peaked at $6.36M in Q1 2026.
  • 1,045 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Opal Capital's 13F filing for Q2 2026, filed 5 Aug 2026.